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Edited by Sandro SonninoAbstract Ceramide is a key metabolite in the pathway of sphin-
golipid biosynthesis. In mammals, ceramide is synthesized by N-
acylation of a sphingoid long-chain base by a family of ceramide
synthases (CerS), each of which displays a high speciﬁcity to-
wards acyl CoAs of diﬀerent chain lengths. We now optimize a
previously-described assay for measuring CerS activity for use
upon over-expression of mammalian CerS, and using these con-
ditions, establish the Km value of each CerS towards sphinga-
nine. Remarkably, the Km values towards sphinganine are all
similar, ranging from 2 to 5 lM, even for CerS proteins that
are able to use more than one acyl CoA for ceramide synthesis
(i.e. CerS4). The availability of this assay will permit further
accurate characterization of the kinetic parameters of mamma-
lian CerS proteins.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Lipid; Sphingolipid; Ceramide; Acyl CoA;
Sphinganine; Assay1. Introduction
Ceramide is both an intermediate in the biosynthetic path-
way of sphingolipids and an important bioactive lipid involved
in a number of molecular signalling pathways [1–4]. Ceramide,
which consists of a sphingoid long-chain base to which a fatty
acid is N-acylated, is synthesized by ceramide synthase (CerS).
This enzyme was ﬁrst assayed biochemically in 1966 [5], and
since then a number of attempts have been made to optimize
assay conditions for CerS ([6–9], Table 1). As with many mem-
brane-bound enzymes, the assay is complicated by the hydro-
phobic nature of the two substrates, namely acyl CoAs, and
sphingoid long-chain bases such as sphinganine or sphingo-
sine.
Recently, CerS were identiﬁed molecularly. The ﬁrst CerS to
be characterized was the yeast enzyme, Lag1/Lac1 [10,11],
which lead to the subsequent discovery of six mammalian
genes, originally named longevity assurance gene homologs
(LASS) genes, but recently renamed CerS [12]. Remarkably,
each one of the six mammalian CerS proteins synthesizes cer-*Corresponding author. Fax: +972 8 9344112.
E-mail address: tony.futerman@weizmann.ac.il (A.H. Futerman).
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doi:10.1016/j.febslet.2007.10.018amide with a unique fatty acid composition. For instance,
CerS1 synthesizes C18-ceramide [13], CerS5 synthesizes C16-
ceramide [14], while CerS2 synthesizes ceramide with longer
acyl chains [16 and Laviad et al., unpublished observations].
Thus, assay of each CerS requires the use of diﬀerent acyl
CoAs in the reaction mixture.
We now demonstrate that despite the high selectivity
towards acyl CoAs, mammalian CerS have a very similar Km
value towards sphinganine, strengthening the notion that the
main biochemical diﬀerence between CerS is in their speciﬁcity
towards acyl CoAs. While obtaining this data, we optimized
conditions for assaying CerS activity in cells over-expressing
CerS, using a modiﬁed detergent-free assay which we previ-
ously described to measure CerS activity in rat liver micro-
somes [7,8], before the molecular identity of CerS had been
elucidated. The lack of detergent is important as some deter-
gents disrupt the activity of membrane-bound enzymes (see
for instance, [17]), including CerS [11]. Using this modiﬁed as-
say, we demonstrate a Km value of all six mammalian CerS to-
wards sphinganine in the low lM range (2–5 lM), signiﬁcantly
lower than that suggested using a variety of other assays and
tissue sources (reviewed in [9]).
2. Materials and methods
2.1. Expression plasmids
Mouse CerS1 and CerS5 were previously cloned in our laboratory
[13,14]. Human CerS3 was sub-cloned from cDNA of keratinocytes
(kindly provided by Dr. Walt Holleran, University of California at
San Francisco) using Pfu polymerase with the following forward and
reverse primers, respectively, having unique restriction sites: 5 0-
CGCGGATCCATGTTTTGGACGTTTAAAG (EcoRI) and 5 0-
CCGGAATTCCATTGGGAATGAGGTGCCT (HindIII). The PCR
products were further sub-cloned into pcDNA3-HA vectors. Human
CerS1, 2, 4, 5, and 6 genes were cloned into a pCMV-Tag2B plasmid
vector (Stratagene), which contains an N-terminal FLAG tag, as fol-
lows: CerS1, kindly provided by S. Michal Jazwinski (Louisiana State
University, New Orleans, Louisiana), CerS2 and 5 were cloned using a
human liver tissue library (Clontech), CerS4 cDNA clones were pur-
chased from ATCC (catalogue number MGC-26850), and CerS6 was
cloned using a human kidney tissue library (Clontech). Genes were in-
serted into pCMV-Tag2B using the following primers ﬂanked with
BamHI (or HinDIII for Cers2) and EcoRI sites: CerS1 (gi18490662),
5 0-CGGGATCCGCGGCGGCGGGGCCC, 5 0-CGGAATTCGGG-
GTTCAGAAGCGC; CerS2 (gi33876084), 5 0-CCGAATTCCTCCA-
GACCTTGTATGATTAC, 5 0-CGAAGCTTGGGAGCGGGGTAG-
TTCCTTGGC; CerS4 (gi33988505), 5 0-CCGGATCCCTGTCCAGT-
TTCAACGAG, 50-GGGAATTCGGCTATGTGGCTGTTGTG; CerS5
(gi21618501), 5 0-AAAGGATCCGCGACAGCAGCACAGGGA-
CC, 5 0-AAAGAATTCCCCTATAGCAACCACCTTACTC; CerS6blished by Elsevier B.V. All rights reserved.
Table 1
Conditions used for assaying CerS activity in vitro
Tissue source Buﬀer Cation Detergent Sphingoid base and acyl CoA Original
Refs.
Other
Refs.
Liver microsomes Tris None Tween 20 Sphingosine (coated on Celite)/
C16- and C24:1-CoAs
[5]
Brain microsomes Potassium
phosphate
Mg2+ Tween 20 Sphingosine (coated on Celite)/
C16-, C18-, and C18:1-CoAs
[6] [25]
Liver microsomes Potassium
phosphate
None None Sphingosine/C16-CoA [9]
Live microsomes, Hek
cell microsomes or
homogenates
Hepes Mg2+ None Sphinganine/C16-CoA [7] [8,13,14,20,
23,26,27]
Partially puriﬁed cellular
fraction
Tris None Tween 20 Sphingosine/C18-CoA [28] [24]
HEK cell lysate Hepes None Digitonin with
long-chain CoA
(C20 and above)
Sphinganine/C14-, C16-, C18-,
C18:1-, C20-, C22-, C24- and
C26-CoAs
[16]
Yeast microsomes Hepes Mg+2 None Sphinganine/hexacosanoic (C26)
acid and CoAa
[11]
Yeast microsomes Tris None Zwittergent Sphinganine/C16-, and C26-CoA [10]
HeLa cell microsomes Potassium
phosphate
Mg2+ None C17-sphinganine/C16-, C18-, and
C18:1-CoAs
[21]
The table lists a number of the common published procedures for assaying CerS activity. Reactions were always performed at 37 C, pH 7.4, except
Schorling et al. [11] who assayed yeast CerS at 24 C, pH 6.8. In some cases, a number of other factors were added to the assay reaction mixtures
(such as dithiothreoitol and propylene glycol); however, the rationale behind use of these factors is not always stated, and these factors have therefore
been excluded from the table.
aFree fatty acid and CoA were added to the reaction mixture to generate acyl CoA, in the presence of an ATP regenerating system.
Table 2
CerS proteins used in the current study, and their acyl CoA speciﬁcities
CerS Fatty acyl CoA References
m/hCerS1a Stearoyl (C18) CoA [13]
hCerS2 Lignoceroyl (C24) CoA [16]
hCerS3 Lignoceroyl (C24) CoA [19]
m/hCerS4 Stearoyl (C18) CoA and
arachidoyl (C20) CoA
[14]
m/hCerS5 Palmitoyl (C16) CoA [14]
hCerS6 Palmitoyl (C16) CoA [16]
am, mouse; h, human.
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GAATTCTTAATCATCCATGGAGC. The PCR products and
pCMV-Tag2B were digested with BamH1–EcoR1 (or EcoR1–HindIII
for CerS2), ligated, and transformed into E. coli DH5a (Invitrogen).
Vector construct inserts were veriﬁed by direct sequencing.
2.2. Cell culture and transfection
Human embryonic kidney (Hek) 293T cells and COS cells were cul-
tured in Dulbecco’s modiﬁed Eagle’s medium (Gibco) supplemented
with 10% fetal calf serum, 100 IU/ml penicillin, and 100 lg/ml strepto-
mycin. Hek cells were transfected using the calcium phosphate method,
and COS cells were transfected using a jetPEI, DNA in vitro trans-
fection reagent (Polypus transfection).0 50 100 150 200 250
0
Protein (µg)
Fig. 1. CerS activity as a function of protein concentration. Homog-
enates were prepared from (A) Hek and (B) COS cells over-expressing2.3. Harvesting cells, homogenization and protein estimation
Hek cells, at 90% conﬂuence, were removed from culture dishes
using trypsin (0.25%, w/v) followed by centrifugation (4 min,
150 · gav). Cell pellets were then washed with phosphate buﬀer saline
and homogenized in 20 mM HEPES–KOH, pH 7.4, 25 mM KCl,
250 mM sucrose, and 2 mM MgCl2 containing a protease inhibitor
cocktail (Sigma). Protein estimation was performed by the Bradford
protein assay (BioRad).CerS proteins. Assays were performed using increasing amounts of
protein and 0.25 lCi of [4,5-3H] sphinganine/15 lM sphinganine/
20 lM defatted-bovine serum albumin, and 50 lM of the respective
acyl CoA for each CerS (as shown in Table 2), for 20 min at 37 C.
Results are means ± S.D.; n = 1–5 for Hek cells, and n = 1–2 for COS
cells.2.4. Ceramide synthase assay
The assay was based on that developed for determining CerS activity
in rat liver microsomes [7]. Brieﬂy, cell homogenates were incubated
with [4,5-3H] sphinganine (speciﬁc activity of 15 Ci/mmol, preparedas in [7])/sphinganine (Matreya, Pleasant Gap, PA)/20 lM defatted-
bovine serum albumin (Sigma), and 50 lM of the respective acyl
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Fig. 2. CerS activity as a function of time of the reaction. CerS, expressed in Hek cells, were assayed as in Fig. 1, but using increasing reaction times.
Results are means ± S.D., n = 2.
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S. Lahiri et al. / FEBS Letters 581 (2007) 5289–5294 5291CoA (Avanti Polar Lipids, Alabster, AL) for each CerS (as shown in
Table 2). The time of the reaction, and the amount of protein used,
is given in each ﬁgure legend. Reactions were terminated using chloro-
form/methanol (1/2; v/v), and lipids extracted [18]. Levels of dihydro-
ceramide synthesis were determined by thin-layer chromatography
using chloroform/methanol/2 M ammonium hydroxide (40/10/1; v/v/v)
as developing solvent; dihydroceramides were identiﬁed using authen-
tic standards. [3H] Lipids were visualized using a phosphorimaging
screen (Fuji, Tokyo, Japan), recovered from TLC plates by scraping
the silica directly into scintillation vials, and quantiﬁed by liquid scin-
tillation counting.0 25 50 75 100
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Fig. 3. Comparison of the activity of mouse and human CerS proteins.
CerS activity was assayed as in Fig. 1 for human and mouse CerS1 (A)
and CerS5 (B) expressed in Hek cells. Results are from a typical
experiment repeated twice.3. Results and discussion
Since CerS activity was ﬁrst measured [5], a number of dif-
ferent methods have been developed for assaying this enzyme
(Table 1). Due to the hydrophobic nature of the substrates,
many of the assays have used detergents (i.e. Tween 20, digito-
nin) to solubilize the substrates, even though detergents can
have deleterious eﬀects on the activity of membrane-bound en-
zymes. Some years ago, we developed a detergent-free assay
for CerS [7]. The basis of this assay was the use of defatted bo-
vine serum albumin (BSA) as a carrier for the substrates. Com-
plexes of acyl CoAs and sphinganine with BSA are prepared,
and in the presence of cell or membrane homogenates, the
two substrates rapidly equilibrate with donor membranes
where they are metabolised to ceramide. Moreover, in the ab-
sence of BSA, the rate of the reaction is signiﬁcantly reduced
probably due to the detergent-like eﬀects of high aqueous con-
centrations of acyl CoAs. Using this assay, we were able to
5292 S. Lahiri et al. / FEBS Letters 581 (2007) 5289–5294determine the topology of the CerS reaction in intact micro-
somes, and to obtain optimal conditions for assaying CerS
activity in rat liver microsomes, using a ratio of BSA to acyl
CoA of 1:3–4, 40 min reaction time, and up to 600 lg of pro-
tein [7].
The characterization of the CerS assay was performed be-
fore the molecular identiﬁcation of the CerS proteins, and
has recently been used by a number of laboratories to measure
CerS activity upon their over-expression in cell lines
[13,14,16,19–23]. Thus, we now characterize this assay more
fully to enable its use such that accurate kinetic parameters
can be measured. We used sphinganine as long-chain base,
and acyl CoAs according to the speciﬁc acyl CoA preference
of each CerS (Table 2). Reactions were linear with respect to
protein for up to 25–50 lg for CerS1, CerS6 and CerS5 in
Hek cells, but for higher amounts of protein (up to 250 lg)
for the other CerS with only low levels of activity detected
using 25–50 lg of protein (Fig. 1A). In contrast, CerS activity
in COS cells was highest upon over-expression of CerS2 or 3
(Fig. 1B), even though the same amount of plasmid was usedC
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Fig. 4. Determination of Km values towards sphinganine for CerS proteins
Fig. 1, but using increasing amounts of [4,5-3H] sphinganine/sphinganine, suc
same for each sphinganine concentration. The acyl CoAs used were as listed i
C18 and C20 CoAs. Values are means ± S.D., n = 2–3. Km values are givenfor transfection of the two diﬀerent cell types (17.5 lg DNA
per 10 cm culture dish). Reactions were linear with respect to
time for up to 20 min for all CerS (Fig. 2). As some of these
proteins were tagged by either an HA or a FLAG tag, we at-
tempted to determine their expression levels by Western blot-
ting. However, despite numerous attempts using a variety of
conditions, we were unable to correlate expression levels with
levels of CerS activity, and thus were unable to estimate
whether diﬀerent CerS have diﬀerent Vmax values. It should
therefore be noted that conditions established for over-expres-
sion of CerS in one cell line cannot be extrapolated to another
cell line, and thus need to be rigorously established for each
CerS in the cell line of choice for over-expression.
The sequence of CerS proteins is very similar between mouse
and human, and both sources have been used for characteriza-
tion of CerS. To determine whether these proteins have similar
activities, we over-expressed human and mouse CerS1 and
Cers5 in Hek cells, and compared their activities. No diﬀer-
ences in activity between human or mouse CerS was observed
(Fig. 3).CerS2
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. Assays were performed on CerS proteins expressed in Hek cell as in
h that the ratio between [4,5-3H] sphinganine and sphinganine was the
n Table 2; for CerS4, the Km towards sphinganine was compared using
in Table 3.
Table 3
Km values of CerS towards sphinganine
CerS Km towards sphinganine (lM)
mCerS1 2.5 ± 0.7
hCerS2 4.8 ± 0.4
hCerS3 1.7 ± 0.4
hCerS4 (C18 CoA) 1.8 ± 0.4
hCerS4 (C20 CoA) 1.8 ± 0.2
mCerS5 1.8 ± 0.4
hCerS6 2.0 ± 0.6
hCerS4 was assayed using either C18 or C20 CoA as indicated; all
other CerS were assayed using the acyl CoAs listed in Table 2. Values
are means ± S.D. n = 3, except for hCerS2 where n = 2. r2 values were
between 0.90 (CerS5 and 6) and 0.97 (CerS4).
S. Lahiri et al. / FEBS Letters 581 (2007) 5289–5294 5293Finally, and of most signiﬁcance, we determined the Km
value of each CerS towards sphinganine using amounts of pro-
tein (Fig. 1) and times (Fig. 2) for which the rate of the reac-
tion was within the linear range, and using the CoAs to
which each CerS displays the highest speciﬁcity (Table 2).
Under these conditions, reactions proceeded according to clas-
sical Michaelis–Menten kinetics (Fig. 4). The Km value of all
CerS were in the low lM range (Table 3). CerS2 had a Km,
of 5 lM, whereas the other ﬁve CerS had a Km of 2 lM
(Table 3). Remarkably, CerS4, which can use either C18-
CoA or C20-CoA [14], had an identical Km value towards
sphinganine irrespective of the acyl CoA chain length. This
strongly supports the notion that the main biochemical diﬀer-
ence between the CerS proteins is in their use of acyl CoAs,
and that the long-chain base binding site may be similar be-
tween CerS, although this cannot exclude the possibility that
diﬀerent CerS have diﬀerent aﬃnities towards diﬀerent long-
chain bases, as appears to be the case with CerS5 [14].
It should also be noted that the Km values reported herein
are considerably lower than some reported earlier (see, for in-
stance, [24]), in which values as high as 300 lM were obtained
(reviewed in [9]). Whether this is due to the use of detergents in
some of these assays (Ref. [24] and Table 1) is not known, but
the assay described in the current study provides a means to
accurately determine kinetic parameters of CerS activity, and
is particularly suitable now that the molecular identity of the
CerS proteins has been established.
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